ResearcherShaare Zedek Medical CenterActive in the last 2 years

Ora Solange Rosengarten

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0009-0000-9274-1866; OpenAlex author ID A5005902146.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1
Pancreatic cancer trials: 1 (principal investigator on 1)
Pancreatic cancer grants: 0
Collaborators: 11

Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 trial

Papers 1

A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma. Co-author DOI 10.1007/s12029-010-9197-1 ↗

Trials 1

Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy Principal investigator NCT06478862 ↗

Closest collaborators

The 11 strongest of 11 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Ravit Geva · 1 shared trial, 2024
- Trial Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy NCT06478862 ↗
Tali Levy · 1 shared trial, 2024
- Trial Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy NCT06478862 ↗
Nirit Yarom · 1 shared trial, 2024
- Trial Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy NCT06478862 ↗
Amichai Meirovitz · 1 shared trial, 2024
- Trial Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy NCT06478862 ↗
Ruth Peretz · 1 shared trial, 2024
- Trial Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy NCT06478862 ↗
Ofer Purim · 1 shared trial, 2024
- Trial Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy NCT06478862 ↗
Eileen Mary O'Reilly · 1 shared paper, 2011
- Paper A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma. DOI 10.1007/s12029-010-9197-1 ↗
Andrew S. Epstein · 1 shared paper, 2011
- Paper A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma. DOI 10.1007/s12029-010-9197-1 ↗
David Paul Kelsen · 1 shared paper, 2011
- Paper A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma. DOI 10.1007/s12029-010-9197-1 ↗
Maeve Aine Lowery · 1 shared paper, 2011
- Paper A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma. DOI 10.1007/s12029-010-9197-1 ↗
Amiel Segal · 1 shared paper, 2011
- Paper A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma. DOI 10.1007/s12029-010-9197-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.